glp-1 euglycemic dka Frontiers Beyond Weight Loss: ED Implications

Sofo et al., 2005

Treatment after failed surgery or radiation may include medication redesign, nerve blocks, botulinum toxin, repeat imaging, selected repeat procedures, or a non-surgical pain control plan

WHO officials emphasized the need for expanding production, improving affordability and creating procurement mechanisms such as pooled purchasing that have worked in large-scale health programs like HIV, to ensure equitable access to GLP-1s

Weight regain: When a person stops taking GLP-1 medications, the side effects of appetite suppression tend to go away, making weight gain common

Improvements in skin tone and brightness may diminish gradually after stopping use